Viewing StudyNCT00363727



Ignite Creation Date: 2024-05-05 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00363727
Status: COMPLETED
Last Update Posted: 2017-01-18
First Post: 2006-08-07

Brief Title: Onset Motor Complications Using REQUIP CR Ropinirole Controlled-release As Add-on Therapy To L-dopa In Parkinsons
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Dyskinesias
Parkinsons Disease
Parkinson Disease
Keywords:
Name View
controlled release ropinirole View
dyskinesia View
SINEMET View
Parkinsons disease View